[96a5a0]: / output / allTrials / logical / NCT00777582_logical.json

Download this file

683 lines (683 with data), 32.8 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
{
"info": {
"nct_id": "NCT00777582",
"official_title": "A Phase I, Randomised, 2 Period Cross Over Study to Determine the Comparative Bioavailability of Two Different Oral Formulations of AZD2281 in Cancer Patients With Advanced Solid Tumours",
"inclusion_criteria": "* Histologically confirmed malignant advanced solid tumour, which is refractory to standard therapies (except Group 8 patients who must not be platinum refractory) or for which no suitable effective standard therapy exists\n* Patients must have adequate organ and bone marrow function measured within 7 days prior to administration of study treatment\n* Female patients must have evidence of non-child bearing status: negative urine or serum pregnancy test within 7 days of study treatment for women of child bearing, or postmenopausal status\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 130 Years",
"exclusion_criteria": "* Patients receiving chemotherapy, radiotherapy (except for palliative reasons) or any other anti-cancer therapy within 4 weeks of the last dose prior to study entry. Patients may continue the use of biphosphonates for bone metastases and corticosteroids\n* Patients with symptomatic uncontrolled brain metastases\n* Major surgery within 2 weeks of starting study and patients must have recovered from any effects of any major surgery\n* Patients who are platinum refractory (Group 8 only)\n* Patients with myelodysplastic syndrome/acute myeloid leukaemia (Group 8 only).",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Histologically confirmed malignant advanced solid tumour, which is refractory to standard therapies (except Group 8 patients who must not be platinum refractory) or for which no suitable effective standard therapy exists",
"criterions": [
{
"exact_snippets": "Histologically confirmed malignant advanced solid tumour",
"criterion": "malignant advanced solid tumour",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"exact_snippets": "refractory to standard therapies",
"criterion": "tumour refractory status",
"requirement": {
"requirement_type": "refractory status",
"expected_value": "refractory to standard therapies"
}
},
{
"exact_snippets": "no suitable effective standard therapy exists",
"criterion": "availability of suitable effective standard therapy",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
},
{
"exact_snippets": "Group 8 patients ... must not be platinum refractory",
"criterion": "platinum refractory status for Group 8 patients",
"requirement": {
"requirement_type": "refractory status",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Histologically confirmed malignant advanced solid tumour",
"criterion": "malignant advanced solid tumour",
"requirement": {
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
},
{
"or_criteria": [
{
"exact_snippets": "refractory to standard therapies",
"criterion": "tumour refractory status",
"requirement": {
"requirement_type": "refractory status",
"expected_value": "refractory to standard therapies"
}
},
{
"exact_snippets": "no suitable effective standard therapy exists",
"criterion": "availability of suitable effective standard therapy",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
}
]
},
{
"or_criteria": [
{
"not_criteria": {
"exact_snippets": "Group 8 patients ... must not be platinum refractory",
"criterion": "platinum refractory status for Group 8 patients",
"requirement": {
"requirement_type": "refractory status",
"expected_value": false
}
}
},
{
"exact_snippets": "Group 8 patients ... must not be platinum refractory",
"criterion": "platinum refractory status for Group 8 patients",
"requirement": {
"requirement_type": "refractory status",
"expected_value": false
}
}
]
}
]
}
},
{
"identified_line": {
"line": "* Patients must have adequate organ and bone marrow function measured within 7 days prior to administration of study treatment",
"criterions": [
{
"exact_snippets": "adequate organ and bone marrow function",
"criterion": "organ function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
},
{
"exact_snippets": "adequate organ and bone marrow function",
"criterion": "bone marrow function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "adequate organ and bone marrow function",
"criterion": "organ function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
},
{
"exact_snippets": "adequate organ and bone marrow function",
"criterion": "bone marrow function",
"requirement": {
"requirement_type": "adequacy",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Female patients must have evidence of non-child bearing status: negative urine or serum pregnancy test within 7 days of study treatment for women of child bearing, or postmenopausal status",
"criterions": [
{
"exact_snippets": "Female patients must have evidence of non-child bearing status",
"criterion": "non-child bearing status",
"requirement": {
"requirement_type": "evidence",
"expected_value": true
}
},
{
"exact_snippets": "negative urine or serum pregnancy test within 7 days of study treatment for women of child bearing",
"criterion": "pregnancy test",
"requirement": {
"requirement_type": "result",
"expected_value": "negative"
}
},
{
"exact_snippets": "negative urine or serum pregnancy test within 7 days of study treatment for women of child bearing",
"criterion": "pregnancy test",
"requirement": {
"requirement_type": "timing",
"expected_value": "within 7 days of study treatment"
}
},
{
"exact_snippets": "postmenopausal status",
"criterion": "menopausal status",
"requirement": {
"requirement_type": "status",
"expected_value": "postmenopausal"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Female patients must have evidence of non-child bearing status",
"criterion": "non-child bearing status",
"requirement": {
"requirement_type": "evidence",
"expected_value": true
}
},
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "negative urine or serum pregnancy test within 7 days of study treatment for women of child bearing",
"criterion": "pregnancy test",
"requirement": {
"requirement_type": "result",
"expected_value": "negative"
}
},
{
"exact_snippets": "negative urine or serum pregnancy test within 7 days of study treatment for women of child bearing",
"criterion": "pregnancy test",
"requirement": {
"requirement_type": "timing",
"expected_value": "within 7 days of study treatment"
}
}
]
},
{
"exact_snippets": "postmenopausal status",
"criterion": "menopausal status",
"requirement": {
"requirement_type": "status",
"expected_value": "postmenopausal"
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
},
{
"identified_line": {
"line": "Must have maximum age of 130 Years",
"criterions": [
{
"exact_snippets": "maximum age of 130 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 130,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "maximum age of 130 Years",
"criterion": "age",
"requirement": {
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 130,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Patients receiving chemotherapy, radiotherapy (except for palliative reasons) or any other anti-cancer therapy within 4 weeks of the last dose prior to study entry. Patients may continue the use of biphosphonates for bone metastases and corticosteroids",
"criterions": [
{
"exact_snippets": "Patients receiving chemotherapy",
"criterion": "chemotherapy",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "Patients receiving ... radiotherapy (except for palliative reasons)",
"criterion": "radiotherapy",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "Patients receiving ... radiotherapy (except for palliative reasons)",
"criterion": "radiotherapy",
"requirement": {
"requirement_type": "purpose",
"expected_value": "palliative reasons"
}
},
{
"exact_snippets": "Patients receiving ... any other anti-cancer therapy",
"criterion": "anti-cancer therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
},
{
"exact_snippets": "Patients may continue the use of biphosphonates for bone metastases",
"criterion": "biphosphonates",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
},
{
"exact_snippets": "Patients may continue the use of ... corticosteroids",
"criterion": "corticosteroids",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Patients receiving chemotherapy",
"criterion": "chemotherapy",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Patients receiving ... radiotherapy (except for palliative reasons)",
"criterion": "radiotherapy",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
},
{
"not_criteria": {
"exact_snippets": "Patients receiving ... radiotherapy (except for palliative reasons)",
"criterion": "radiotherapy",
"requirement": {
"requirement_type": "purpose",
"expected_value": "palliative reasons"
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Patients receiving ... any other anti-cancer therapy",
"criterion": "anti-cancer therapy",
"requirement": {
"requirement_type": "timing",
"expected_value": {
"operator": "<",
"value": 4,
"unit": "weeks"
}
}
}
]
}
]
},
{
"not_criteria": {
"or_criteria": [
{
"exact_snippets": "Patients may continue the use of biphosphonates for bone metastases",
"criterion": "biphosphonates",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
},
{
"exact_snippets": "Patients may continue the use of ... corticosteroids",
"criterion": "corticosteroids",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
}
]
}
}
]
}
},
{
"identified_line": {
"line": "* Patients with symptomatic uncontrolled brain metastases",
"criterions": [
{
"exact_snippets": "symptomatic uncontrolled brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "symptom presence",
"expected_value": true
}
},
{
"exact_snippets": "symptomatic uncontrolled brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "symptomatic uncontrolled brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "symptom presence",
"expected_value": true
}
},
{
"exact_snippets": "symptomatic uncontrolled brain metastases",
"criterion": "brain metastases",
"requirement": {
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
}
]
}
},
{
"identified_line": {
"line": "* Major surgery within 2 weeks of starting study and patients must have recovered from any effects of any major surgery",
"criterions": [
{
"exact_snippets": "Major surgery within 2 weeks of starting study",
"criterion": "major surgery",
"requirement": {
"requirement_type": "time since surgery",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
},
{
"exact_snippets": "patients must have recovered from any effects of any major surgery",
"criterion": "recovery from major surgery",
"requirement": {
"requirement_type": "recovery status",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"not_criteria": {
"exact_snippets": "Major surgery within 2 weeks of starting study",
"criterion": "major surgery",
"requirement": {
"requirement_type": "time since surgery",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
}
},
{
"not_criteria": {
"exact_snippets": "patients must have recovered from any effects of any major surgery",
"criterion": "recovery from major surgery",
"requirement": {
"requirement_type": "recovery status",
"expected_value": true
}
}
}
]
}
},
{
"identified_line": {
"line": "* Patients who are platinum refractory (Group 8 only)",
"criterions": [
{
"exact_snippets": "Patients who are platinum refractory",
"criterion": "platinum refractory",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "Group 8 only",
"criterion": "group",
"requirement": {
"requirement_type": "membership",
"expected_value": "8"
}
},
"then_criteria": {
"exact_snippets": "Patients who are platinum refractory",
"criterion": "platinum refractory",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Patients with myelodysplastic syndrome/acute myeloid leukaemia (Group 8 only).",
"criterions": [
{
"exact_snippets": "myelodysplastic syndrome",
"criterion": "myelodysplastic syndrome",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "acute myeloid leukaemia",
"criterion": "acute myeloid leukaemia",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"or_criteria": [
{
"exact_snippets": "myelodysplastic syndrome",
"criterion": "myelodysplastic syndrome",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "acute myeloid leukaemia",
"criterion": "acute myeloid leukaemia",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
{
"exact_snippets": "Group 8 only",
"criterion": "Group",
"requirement": {
"requirement_type": "membership",
"expected_value": "Group 8"
}
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}